Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs.

The alliance will combine HeartBeam's ECG device with AccurKardia's monitoring software.  

The digital mental health tool maker will retire its teen-focused app as of June 30.

The health insurer unintentionally exposed the personal data of 4.7 million people to Google through a misconfigured analytics tool used between 2021 and 2024.

The company will use the funds to expand access to its AI-powered offering and improve operational efficiencies.